NORTHRIDGE, Calif.--(BUSINESS WIRE)--Avita Medical Ltd. (ASX: AVH), the regenerative medicine company, announced today that it has expanded its sales and marketing operations into three new countries: Russia, The Netherlands and Portugal. The Company has previously established commercial operations in Australia, France, Germany and the United Kingdom.
